TD Private Client Wealth’s Amedisys AMED Stock Holding History

TD Private Client Wealth’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-36	Closed	-$3.29K	–	1216
2023 Q2	$3.29K	Hold	36	–	–	﹤0.01%	1147
2023 Q1	$2.65K	Hold	36	–	–	﹤0.01%	1142
2022 Q4	$3.01K	Sell	36 -106	-75%	-$9.56K	﹤0.01%	1102
2022 Q3	$13.7K	Hold	142	–	–	﹤0.01%	961
2022 Q2	$14.9K	Hold	142	–	–	﹤0.01%	958
2022 Q1	$24.5K	Buy	142 +102	+255%	+$15.2K	﹤0.01%	911
2021 Q4	$6.47K	Sell	40 -565	-93%	-$90.8K	﹤0.01%	937
2021 Q3	$90.2K	Hold	605	–	–	﹤0.01%	642
2021 Q2	$148K	Buy	605 +6	+1%	+$1.57K	0.01%	563
2021 Q1	$159K	Buy	599 +75	+14%	+$21.2K	0.01%	530
2020 Q4	$154K	Hold	524	–	–	0.01%	513
2020 Q3	$124K	Buy	+524	New	+$119K	0.01%	506

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

TD Private Client Wealth's AMED Position: Q3 2023 in Review

TD Private Client Wealth sold out of Amedisys (AMED) in Q3 2023, closing a stake of 36 shares — an estimated $3.29K sold.

TD Private Client Wealth first reported a position in AMED in Q3 2020 and held it in 12 quarters. The position peaked at $159K in Q1 2021. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

TD Private Client Wealth reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
TD Private Client Wealth sold 36 Amedisys shares in Q3 2023, an estimated $3.29K.
TD Private Client Wealth first reported a position in Amedisys in Q3 2020 and held it in 12 quarters.
TD Private Client Wealth's Amedisys position peaked at $159K in Q1 2021.
286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on TD Private Client Wealth's 13F filing for Q3 2023, filed 16 Aug 2024.